Chronic kidney disease (CKD) includes a range of various pathological processes along with abnormal kidney function and a gradual reduction in glomerular filtration rate, whose last stage is End-Stage Renal Disease (ESRD) (
1). In fact, ESRD is a kidney condition where about 90% of the kidney function is lost (
2). The annual incidence of the disease is reported to be 53 cases per one million people (
3). The prevalence of CKD is 8.66% in Africa, 13.10% in India, 13.74% in Japan, 14.71% in Australia, 15.45% in the USA, and 18.38% in Europe (
4-
6).
In case the kidney function reaches 10 to 15% of its normal function, alternative methods will be needed (
7). Hemodialysis is one of the most successful alternative therapies for kidney function (
3,
8). The purpose of hemodialysis is to remove waste products, stabilize the internal environment of the body, and remove toxins to prevent permanent injury or death (
9-
11). There are more than 13,000 dialysis patients in Iran, and about 150,000 dialysis sessions are held every month to treat these patients. The number of patients undergoing hemodialysis increases by about 15% annually (
12). Cardiovascular diseases and inadequacy of dialysis are the main determinants of disability and mortality in dialysis patients (
3,
4).
Inadequate dialysis can increase the disease complications, duration of hospitalization, and the costs incurred on the patients (
13,
14). Hence, dialysis adequacy affects the long-term prognosis of chronic hemodialysis patients, and its evaluation and enhancement are extremely important in reducing mortality in dialysis patients (
15,
16)
If dialysis adequacy is better, the complications of uremia on various organs of the body will be less, and mortality will reduce (
17,
18). About 11% of patients do not meet the minimum standard of dialysis adequacy (
19). Increasing the efficiency of dialysis adequacy is of great significance as it can enhance health and increase life expectancy (
20,
21).
Presently, the most reliable method of measuring and evaluating dialysis adequacy is the Kt/V, K is filterability to purify urea, T is the duration of hemodialysis, V the volume of urea distribution in body fluids. According to the American Association of Kidney Patients, 1.2 < Kt/V shows hemodialysis adequacy (
19,
20).
Urea reduction ratio (URR) is another method for measuring the dialysis adequacy. This method is expressed as a percentage (
22). In the studies conducted so far, the standard value of Kt/V in patients undergoing dialysis three times a week has been determined to be 1.2, below which the number of uremic complications increases (
23). Previous studies have reported a 0.7 reduction in mortality per 0.1 increase in Kt/V and an 11% decrease in mortality per 5% increase in URR (
24). The results of a study by the Dallas Dialysis Center show that with an increase in Kt/V from 1.18 to 1.46, the mortality rate decreased from 22.5 to 18% (
25).
Different elements like the ability of the filter to remove and transport waste products, the duration of dialysis sessions, and the rate of blood flow and dialysis fluid have a significant role in achieving effective and efficient dialysis (
26). Despite this increase in the dialysis time, for economic reasons and patient intolerance are not always possible. Moreover, the increase in the dialysis flow rate is not practical given the difficulty in achieving the appropriate speed and imposing complications and consequent patient intolerance for a long time (
26,
27). Thus, other parameters affecting the quality of dialysis, like the ability of the filter membrane, should be considered; however, obstruction of the pores of fine filters by different materials, like small clots formed during hemodialysis, could hinder reaching effective and efficient dialysis (
26). Clot formation during dialysis is a common and unavoidable phenomenon. Owing to the turbulence of blood flow, high blood pressure, and contact of blood with artificial surfaces, the possibility of clot formation increases, and thus dialysis adequacy will decrease (
28,
29).
A common mechanism for coping with this complication is using anticoagulants during hemodialysis (
29). Heparin continues to be used as a preferred medicine by physicians (
30,
31).
To prevent clots, heparin is used in different ways, such as using minimal heparin and heparin-free method with high serum flow (
32). Low cost, easy administration, monitoring of the drug, and its short biological half-life have led to its widespread use during hemodialysis (
33). The proper use of anticoagulants is of high importance in minimizing the risk of bleeding (
34). The normal saline solution, hyperchloremic and hypertonic (with an osmolality of 309 mmol) such that it is recommended as the optimum solution in advanced renal patients (
26,
35).
Various prime dialyzer approaches have a positive effect on increasing dialysis adequacy (
36).